Correvio Pharma 's ROA from the fourth quarter of 2019 to the fourth quarter of 2018 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Correvio Pharma 's ROA in the fourth quarter of 2019?
Correvio Pharma Corp recorded a cumulative net loss of $-35 million during 12 months ending in the fourth quarter of 2019, resulting in a negative return on assets (ROA) of -53.75%.

However, within the Healthcare sector 661 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the third quarter of 2019 from to 4866.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Dec 31 2019) IV. Quarter	0 III. Quarter	0 II. Quarter	0 I. Quarter	(Dec 31 2018) IV. Quarter
Y / Y Total Assets Change	16.37 %	-1.25 %	-1.25 %	-1.25 %	-55.21 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-35	-17	-17	-17	-17
Return On Assets (TTM)	-53.75 %	-26.54 %	-26.46 %	-26.39 %	-26.31 %
CORV's Total Ranking	# 4866	#	#	#	# 4506
Total Assets (TTM) in million	85	59	59	59	73
Seq. Total Assets Change	44.57 %	0 %	0 %	-19.51 %	22.69 %
Seq. Net Income Change	-	-	-	-	-

CORV's 5 Years Annual ROA >> Back to CORV Management Effectiveness >> Compare CORV ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 323
Sector	# 662
Overall	# 4700

Return On Assets Statistics
High	Average	Low
10.08 %	-34.91 %	-59.74 %
(Dec 31 2013)		(Dec 31 2019)

Financial Statements
Correvio Pharma 's Assets	$ 85 million	CORV's Balance sheet
Correvio Pharma 's Income	$ -35 million	Quarterly CORV's Income Statement
CORV's Income by Division		See CORV's Income by Division

Annual Return On Assets	(Dec 31 2019) FY 2019	(Dec 31 2018) FY 2018	(Dec 31 2017) FY 2017	(Dec 31 2016) FY 2016	(Dec 31 2015) FY 2015
Y / Y Total Assets Change	16.37 %	-54.86 %	1.27 %	13.66 %	8.4 %
Total Assets in million	85	73	162	160	141
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-35	-17	-30	-20	-24
Annual Return On Assets	-41.32 %	-22.66 %	-18.39 %	-12.26 %	-17.37 %

CORV's 5 Years Annual ROA >> Back to CORV Management Effectiveness >> Compare CORV ROA to its Competitors

More Return On Assets Ratios
CORV's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
CORV's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for CORV's Competitors
Subscribers only: Roa for Correvio Pharma 's Suppliers
Subscribers only: Return On Assets for CORV's Customers

You may also want to know
CORV's Roi	CORV's Inventory Turnover Ratio	CORV's Growth Rates	CORV's Dividend Comparisons
	CORV's Profitability Ratios	CORV's Asset Turnover Ratio	CORV's Dividend Growth
CORV's Roe	CORV's Valuation Ratios	CORV's Financial Strength Ratios	CORV's Dividend Payout Ratio

Companies with similar Return On Assets at Dec 31 2019, within Healthcare Sector

ROA

Date modified: 2026-09-08T15:09:54+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.